Pfizer has discontinued the supply of FASIGYN (tinidazole) 500 mg tablet blister pack and SIMPLOTAN (tinidazole) 50… https://t.co/j44RNPsRSh
ASHM Report Back
Clinical posts from members and guests of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) from various international medical and scientific conferences on HIV, AIDS, viral hepatitis, and sexual health.
Stand out message regarding Non-Gonococcal Urethritis in men and whether their female partners need to know
Great first day at the 2016 Australasian Sexual Health Conference in Adelaide!
Something that stood out for me today was a study conducted about whether female partners of men with non-gonococcal urethritis (NGU)should be contacted, examined , tested and treated.
The answer was YES.
Female partners of men with NGU have an increased chance of developing symptoms of Pelvic Inflammatory Disease (PID).
Some women report deep pelvic pain, post coital bleeding and/or burning on micturition as symptoms.
These women should be treated as for P.I.D. (important to rule out Bacterial Vaginosis at the same time)
Clinicians should consider the increasing evidence of Mycoplasma Genitalium (MG) resistance to Azithromycin and consider a 7 day course of twice daily Doxycycline 100mg po.
In my experience, Doxycycline is not very well tolerated in a large number of patients. Gastrointestinal side effects and problems with photosensitivity are some of the more common side effects. In remote settings, would clinicians rather treat with Azithromycin 1g po stat on day of consult, examination and testing?
I would love to know what others think about this.